Trial Profile
Investigation of the usefulness of drug change from one type to another type of 5-ASA (5-mesalamine) in the treatment of ulcerative colitis during the relapse state
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 12 May 2016
Price :
$35
*
At a glance
- Drugs Mesalazine (Primary)
- Indications Ulcerative colitis
- Focus Therapeutic Use
- 30 Apr 2013 New trial record